| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJCN/68.4.854 |
| P698 | PubMed publication ID | 9771862 |
| P2093 | author name string | Pierratos A | |
| Cole DE | |||
| Vieth R | |||
| Rubin LA | |||
| Siu S | |||
| Trang HM | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin D | Q175621 | ||
| cholecalciferol | Q139347 | ||
| P304 | page(s) | 854-858 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. | |
| P478 | volume | 68 |
| Q34300668 | 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. |
| Q34396494 | 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype |
| Q35099640 | A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation |
| Q34964853 | A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections |
| Q33455922 | A simple, rapid atmospheric pressure chemical ionization liquid chromatography tandem mass spectrometry method for the determination of 25-hydroxyvitamin D2 and D3. |
| Q38542689 | A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention. |
| Q28743134 | Agreement of blood spot card measurements of vitamin D levels with serum, whole blood specimen types and a dietary recall instrument |
| Q35144471 | Association of urinary calcium excretion with serum calcium and vitamin D levels |
| Q73542212 | Calcium and vitamin D supplementation in nursing home residents |
| Q46198037 | Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis |
| Q37125654 | Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study |
| Q42672742 | Circulating 25-Hydroxy Vitamin D Relative to Vitamin D Receptor Polymorphism after Vitamin D3 Supplementation in Breast Cancer Women: A Randomized, Double-Blind Controlled Clinical Trial |
| Q36897449 | Clinical challenges in the management of osteoporosis |
| Q33576198 | Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease. |
| Q87930125 | Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome |
| Q24620233 | Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets |
| Q26862535 | Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis |
| Q38580365 | Determinants of parathyroid hormone response to vitamin D supplementation: a systematic review and meta-analysis of randomised controlled trials |
| Q46381348 | Diabetes and the vitamin d connection |
| Q35853928 | Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults |
| Q34907280 | Dietary calcium and vitamin D2 supplementation with enhanced Lentinula edodes improves osteoporosis-like symptoms and induces duodenal and renal active calcium transport gene expression in mice |
| Q92748276 | Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial |
| Q36288846 | Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial |
| Q37766188 | Does vitamin D protect against cardiovascular disease? |
| Q35450039 | Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus |
| Q40058675 | Effect of maternal vitamin D3 supplementation on maternal health, birth outcomes, and infant growth among HIV-infected Tanzanian pregnant women: study protocol for a randomized controlled trial |
| Q84834712 | Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease |
| Q38865661 | Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance |
| Q89495045 | Effects of Vitamin D2 (Ergocalciferol) and D3 (Cholecalciferol) on Atlantic Salmon (Salmo salar) Primary Macrophage Immune Response to Aeromonas salmonicida subsp. salmonicida Infection |
| Q40293896 | Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency |
| Q37063935 | Effects of vitamin D3 and calcium supplementation on serum levels of tocopherols, retinol, and specific vitamin D metabolites |
| Q35677318 | Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis |
| Q36163191 | Efficacy of high dose Vitamin D supplementation in improving serum 25(OH)D among migrant and non migrant population: a retrospective study |
| Q37622507 | Epidemiology of vitamin D in health and disease |
| Q46115517 | Ergocalciferol from mushrooms or supplements consumed with a standard meal increases 25-hydroxyergocalciferol but decreases 25-hydroxycholecalciferol in the serum of healthy adults |
| Q84242987 | Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD |
| Q37887174 | European cystic fibrosis bone mineralisation guidelines |
| Q64080341 | Evaluation and comparison of Vitamin D receptors in periodontal ligament tissue of Vitamin D-deficient chronic periodontitis patients before and after supplementation of Vitamin D3 |
| Q37254581 | Evaluation and correction of low vitamin D status |
| Q36158130 | Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults |
| Q37195487 | Evaluation of vitamin D repletion regimens to correct vitamin D status in adults |
| Q33649014 | Extra-skeletal effects of vitamin D deficiency in chronic kidney disease |
| Q35894937 | Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation |
| Q36134708 | Factors predicting vitamin D response variation in non-Hispanic white postmenopausal women |
| Q34221447 | Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects |
| Q39252599 | Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications |
| Q24618917 | Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults |
| Q33395472 | Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies |
| Q36710005 | High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum |
| Q30524139 | High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial |
| Q34262950 | Hypocalcemia: updates in diagnosis and management for primary care. |
| Q51408633 | Hypovitaminosis D in glycogen storage disease type I. |
| Q34619090 | IOF position statement: vitamin D recommendations for older adults |
| Q26801494 | Immune Modulation by Vitamin D and Its Relevance to Food Allergy |
| Q34397763 | Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology |
| Q27000724 | Impact of vitamin D on infectious disease |
| Q36520188 | Implications of vitamin D deficiency in pregnancy and lactation |
| Q42548423 | Improving the measurement of 25-hydroxyvitamin D. |
| Q34060129 | Influence of Season, Ethnicity, and Chronicity on Vitamin D Deficiency in Traumatic Spinal Cord Injury |
| Q44760703 | Lack of generalizable evidence of the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis: comment on the article by Ringe et al. |
| Q88809779 | Lactase persistence may explain the paradoxical findings of high vitamin D concentrations in Europeans living in areas of low UV-B irradiation |
| Q46639642 | Les régimes végétariens chez les enfants et les adolescents |
| Q60572282 | Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months |
| Q35043618 | Low vitamin D status: definition, prevalence, consequences, and correction |
| Q37065058 | Mineral metabolism and bone disease after bariatric surgery and ways to optimize bone health |
| Q38807651 | Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics |
| Q31044841 | Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data |
| Q90178001 | Nutrition assessment of vitamin A and vitamin D in northeast Chinese population based-on SPE/UPLC/PDA |
| Q37400305 | Nutritional therapies (including fosteum). |
| Q35278465 | Nutritional vitamin D supplementation in dialysis: a randomized trial |
| Q22305436 | Photobiology of vitamin D in mushrooms and its bioavailability in humans |
| Q93044591 | Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life |
| Q30313908 | Plant Oils as Potential Sources of Vitamin D. |
| Q47830524 | Plant-Based Nutrition: An Essential Component of Cardiovascular Disease Prevention and Management. |
| Q35895555 | Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults |
| Q22121937 | Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets |
| Q37423791 | Possible Health Implications and Low Vitamin D Status during Childhood and Adolescence: An Updated Mini Review. |
| Q57241717 | Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation |
| Q36128511 | Proceedings of the Rank Forum on Vitamin D. |
| Q91941828 | Quantitative analysis of vitamin D and its main metabolites in human milk by supercritical fluid chromatography coupled to tandem mass spectrometry |
| Q24797001 | Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients |
| Q35860672 | Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. |
| Q33403893 | Serum 25-hydroxyvitamin D is not related to cardiac natriuretic peptide in nulliparous and lactating women |
| Q36361380 | Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection |
| Q22306203 | Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation |
| Q37526569 | Severe osteomalacia presenting with multiple vertebral fractures: a case report and review of the literature |
| Q37311303 | Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. |
| Q35065044 | Skeletal health of children and adolescents with inflammatory bowel disease |
| Q37383672 | Some new food for thought: the role of vitamin D in the mental health of older adults |
| Q22299225 | Sports health benefits of vitamin d |
| Q34402156 | Sunlight and Vitamin D: A global perspective for health |
| Q89550593 | The Effects of Cholecalciferol Supplementation on Vitamin D Status Among a Diverse Population of Collegiate Basketball Athletes: A Quasi-Experimental Trial |
| Q42148097 | The Effects of Fat-soluble Vitamin Administration on Plasma Vitamin Status of Nursing Pigs Differ When Provided by Oral Administration or Injection |
| Q37792351 | The Vitamin D and Cancer Conundrum: Aiming at a Moving Target |
| Q33608847 | The biology and pathology of vitamin D control in bone |
| Q37671345 | The change in plasma 25-hydroxyvitamin D did not differ between breast-fed infants that received a daily supplement of ergocalciferol or cholecalciferol for 3 months. |
| Q74054169 | The effect of conventional vitamin D(2) supplementation on serum 25(OH)D concentration is weak among peripubertal Finnish girls: a 3-y prospective study |
| Q37341826 | The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets. |
| Q91672444 | The effects of three regimens of cholecalciferol (vitamin D3) supplementation on vitamin D deficiency in non-obese and obese females |
| Q35024681 | The effects of vitamin D₂ or D₃ supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial |
| Q30450779 | The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats |
| Q35827565 | The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis |
| Q38680094 | The potential impact of compositional changes in farmed fish on its health-giving properties: is it time to reconsider current dietary recommendations? |
| Q35875077 | The role of vitamers and dietary-based metabolites of vitamin D in prevention of vitamin D deficiency |
| Q30356253 | The role of vitamin D for bone health and fracture prevention. |
| Q24545572 | The role of vitamin D in cancer prevention |
| Q44568127 | The role of vitamin D in tuberculosis |
| Q30234422 | The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention |
| Q38063024 | Transverse myelitis |
| Q37212279 | Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light |
| Q37311307 | Treatment of hypovitaminosis D in infants and toddlers |
| Q64274230 | Urinary metabolic profiles after vitamin D2 versus vitamin D3 supplementation in prediabetes |
| Q41108480 | Vegan diets: practical advice for athletes and exercisers |
| Q34030460 | Vegetarian diets in children and adolescents. |
| Q30425759 | Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation |
| Q41895454 | Vitamin D 2 interacts with Human PrP(c) (90-231) and breaks PrP(c) oligomerization in vitro |
| Q47569259 | Vitamin D Vitamers Affect Vitamin D Status Differently in Young Healthy Males |
| Q37523786 | Vitamin D and adolescent health |
| Q27690804 | Vitamin D and bone health: potential mechanisms. |
| Q39125408 | Vitamin D and mental health in children and adolescents |
| Q37435932 | Vitamin D and prostate cancer risk: a review of the epidemiological literature |
| Q44252883 | Vitamin D and respiratory infection in adults |
| Q38361922 | Vitamin D and risk of CVD: a review of the evidence |
| Q27011804 | Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation |
| Q38739032 | Vitamin D deficiency as a public health issue: using vitamin D2 or vitamin D3 in future fortification strategies. |
| Q36700729 | Vitamin D deficiency at birth among military dependants in Hawai'i |
| Q27022078 | Vitamin D deficiency in India: prevalence, causalities and interventions |
| Q37050482 | Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment |
| Q37203087 | Vitamin D in asthma and future perspectives |
| Q36944593 | Vitamin D in cutaneous carcinogenesis: part I |
| Q36063279 | Vitamin D in health and disease |
| Q34069825 | Vitamin D in organ transplantation |
| Q27500429 | Vitamin D in plants: a review of occurrence, analysis, and biosynthesis |
| Q35117137 | Vitamin D in preventive medicine: are we ignoring the evidence? |
| Q84581673 | Vitamin D in the spotlight--time for urgent action? |
| Q36526889 | Vitamin D insufficiency in congestive heart failure: why and what to do about it? |
| Q34053046 | Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study |
| Q33782547 | Vitamin D insufficiency. |
| Q37778788 | Vitamin D insufficiency: a common and treatable problem in the Irish population |
| Q39136547 | Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia |
| Q33703957 | Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease |
| Q36666317 | Vitamin D replacement for cirrhosis-related bone disease |
| Q35123615 | Vitamin D resistance in chronic kidney disease (CKD). |
| Q37095126 | Vitamin D status in gastrointestinal and liver disease |
| Q39955722 | Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay |
| Q36392482 | Vitamin D supplementation for nonspecific musculoskeletal pain in non-Western immigrants: a randomized controlled trial |
| Q24193850 | Vitamin D supplementation for prevention of cancer in adults |
| Q24201160 | Vitamin D supplementation for prevention of mortality in adults |
| Q24235390 | Vitamin D supplementation for prevention of mortality in adults |
| Q36187587 | Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review |
| Q34975880 | Vitamin D supplementation in the pediatric rheumatology clinic |
| Q37803065 | Vitamin D supplementation: a pharmacologic perspective |
| Q90293622 | Vitamin D-binding protein (rs4588) T/T genotype is associated with anteroseptal myocardial infarction in coronary artery disease patients |
| Q46878273 | Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women |
| Q24655075 | Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D |
| Q40264506 | Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach. |
| Q35388836 | Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose |
| Q30365228 | Vitamin D: a critical and essential micronutrient for human health |
| Q22305599 | Vitamin D: deficiency, sufficiency and toxicity |
| Q33635261 | Vitamin d deficiency in cystic fibrosis |
| Q35207472 | Vitamin d, sunlight and prostate cancer risk |
| Q61446241 | Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial |
| Q38043977 | Which vitamin D oral supplement is best for postmenopausal women? |
| Q34296402 | Why randomized controlled trials of calcium and vitamin D sometimes fail |
| Q45825485 | Hypocalcémie: Mises à jour dans le diagnostic et la prise en charge en soinsprimaires |
Search more.